Rectal carcinoma: Long-term experience with moderately high-dose preoperative radiation and low anterior resection

H. D. Kerman, S. H. Roberson, T. S. Bloom, H. C. Heron, T. E. Yaeger, D. L. Meese, A. H. Ritter, J. T. Tolland, A. E. Spangler

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

This report updated an analysis of a 14-year experience of moderately high-dose (4500 to 5000 cGy) preoperative radiation as an adjuvant to low anterior resection of 95 cases of adenocarcinoma of the rectum. The treatment was well tolerated without treatment-related mortality and with a low incidence (5.2%) of severe complications. The local recurrence rate was 4.2%, and distant failure rate was 10.5%. At 5 years, the actuarial survival rate was 66% and the disease-free survival rate was 64%. At 10 years, the actuarial survival rate and disease-free survival rate were 52%. The authors concluded that moderately high-dose (4500 to 5000 cGy) neoadjuvant radiation in clinically resectable adenocarcinoma of the rectum in which one segment of the anastomosis was in the preoperative radiation field is a safe, effective adjuvant to low anterior resection and that it offered patients excellent local control, long-term survival, and sphincter preservation. Results could be enhanced by chemotherapy, and the authors urged well-designed prospective randomized multicenter trials to determine the most appropriate drugs, dosage, and sequencing of co-adjuvant preoperative radiation therapy and chemotherapy with surgery.

Original languageEnglish (US)
Pages (from-to)2813-2819
Number of pages7
JournalCancer
Volume69
Issue number11
DOIs
StatePublished - 1992

Fingerprint

Survival Rate
Radiation
Carcinoma
Rectum
Disease-Free Survival
Adenocarcinoma
Drug Therapy
Multicenter Studies
Radiotherapy
Recurrence
Survival
Mortality
Incidence
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Kerman, H. D., Roberson, S. H., Bloom, T. S., Heron, H. C., Yaeger, T. E., Meese, D. L., ... Spangler, A. E. (1992). Rectal carcinoma: Long-term experience with moderately high-dose preoperative radiation and low anterior resection. Cancer, 69(11), 2813-2819. https://doi.org/10.1002/1097-0142(19920601)69:11<2813::AID-CNCR2820691129>3.0.CO;2-W

Rectal carcinoma : Long-term experience with moderately high-dose preoperative radiation and low anterior resection. / Kerman, H. D.; Roberson, S. H.; Bloom, T. S.; Heron, H. C.; Yaeger, T. E.; Meese, D. L.; Ritter, A. H.; Tolland, J. T.; Spangler, A. E.

In: Cancer, Vol. 69, No. 11, 1992, p. 2813-2819.

Research output: Contribution to journalArticle

Kerman, HD, Roberson, SH, Bloom, TS, Heron, HC, Yaeger, TE, Meese, DL, Ritter, AH, Tolland, JT & Spangler, AE 1992, 'Rectal carcinoma: Long-term experience with moderately high-dose preoperative radiation and low anterior resection', Cancer, vol. 69, no. 11, pp. 2813-2819. https://doi.org/10.1002/1097-0142(19920601)69:11<2813::AID-CNCR2820691129>3.0.CO;2-W
Kerman, H. D. ; Roberson, S. H. ; Bloom, T. S. ; Heron, H. C. ; Yaeger, T. E. ; Meese, D. L. ; Ritter, A. H. ; Tolland, J. T. ; Spangler, A. E. / Rectal carcinoma : Long-term experience with moderately high-dose preoperative radiation and low anterior resection. In: Cancer. 1992 ; Vol. 69, No. 11. pp. 2813-2819.
@article{87182b051e6440d59579305cb4563200,
title = "Rectal carcinoma: Long-term experience with moderately high-dose preoperative radiation and low anterior resection",
abstract = "This report updated an analysis of a 14-year experience of moderately high-dose (4500 to 5000 cGy) preoperative radiation as an adjuvant to low anterior resection of 95 cases of adenocarcinoma of the rectum. The treatment was well tolerated without treatment-related mortality and with a low incidence (5.2{\%}) of severe complications. The local recurrence rate was 4.2{\%}, and distant failure rate was 10.5{\%}. At 5 years, the actuarial survival rate was 66{\%} and the disease-free survival rate was 64{\%}. At 10 years, the actuarial survival rate and disease-free survival rate were 52{\%}. The authors concluded that moderately high-dose (4500 to 5000 cGy) neoadjuvant radiation in clinically resectable adenocarcinoma of the rectum in which one segment of the anastomosis was in the preoperative radiation field is a safe, effective adjuvant to low anterior resection and that it offered patients excellent local control, long-term survival, and sphincter preservation. Results could be enhanced by chemotherapy, and the authors urged well-designed prospective randomized multicenter trials to determine the most appropriate drugs, dosage, and sequencing of co-adjuvant preoperative radiation therapy and chemotherapy with surgery.",
author = "Kerman, {H. D.} and Roberson, {S. H.} and Bloom, {T. S.} and Heron, {H. C.} and Yaeger, {T. E.} and Meese, {D. L.} and Ritter, {A. H.} and Tolland, {J. T.} and Spangler, {A. E.}",
year = "1992",
doi = "10.1002/1097-0142(19920601)69:11<2813::AID-CNCR2820691129>3.0.CO;2-W",
language = "English (US)",
volume = "69",
pages = "2813--2819",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - Rectal carcinoma

T2 - Long-term experience with moderately high-dose preoperative radiation and low anterior resection

AU - Kerman, H. D.

AU - Roberson, S. H.

AU - Bloom, T. S.

AU - Heron, H. C.

AU - Yaeger, T. E.

AU - Meese, D. L.

AU - Ritter, A. H.

AU - Tolland, J. T.

AU - Spangler, A. E.

PY - 1992

Y1 - 1992

N2 - This report updated an analysis of a 14-year experience of moderately high-dose (4500 to 5000 cGy) preoperative radiation as an adjuvant to low anterior resection of 95 cases of adenocarcinoma of the rectum. The treatment was well tolerated without treatment-related mortality and with a low incidence (5.2%) of severe complications. The local recurrence rate was 4.2%, and distant failure rate was 10.5%. At 5 years, the actuarial survival rate was 66% and the disease-free survival rate was 64%. At 10 years, the actuarial survival rate and disease-free survival rate were 52%. The authors concluded that moderately high-dose (4500 to 5000 cGy) neoadjuvant radiation in clinically resectable adenocarcinoma of the rectum in which one segment of the anastomosis was in the preoperative radiation field is a safe, effective adjuvant to low anterior resection and that it offered patients excellent local control, long-term survival, and sphincter preservation. Results could be enhanced by chemotherapy, and the authors urged well-designed prospective randomized multicenter trials to determine the most appropriate drugs, dosage, and sequencing of co-adjuvant preoperative radiation therapy and chemotherapy with surgery.

AB - This report updated an analysis of a 14-year experience of moderately high-dose (4500 to 5000 cGy) preoperative radiation as an adjuvant to low anterior resection of 95 cases of adenocarcinoma of the rectum. The treatment was well tolerated without treatment-related mortality and with a low incidence (5.2%) of severe complications. The local recurrence rate was 4.2%, and distant failure rate was 10.5%. At 5 years, the actuarial survival rate was 66% and the disease-free survival rate was 64%. At 10 years, the actuarial survival rate and disease-free survival rate were 52%. The authors concluded that moderately high-dose (4500 to 5000 cGy) neoadjuvant radiation in clinically resectable adenocarcinoma of the rectum in which one segment of the anastomosis was in the preoperative radiation field is a safe, effective adjuvant to low anterior resection and that it offered patients excellent local control, long-term survival, and sphincter preservation. Results could be enhanced by chemotherapy, and the authors urged well-designed prospective randomized multicenter trials to determine the most appropriate drugs, dosage, and sequencing of co-adjuvant preoperative radiation therapy and chemotherapy with surgery.

UR - http://www.scopus.com/inward/record.url?scp=0026596469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026596469&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19920601)69:11<2813::AID-CNCR2820691129>3.0.CO;2-W

DO - 10.1002/1097-0142(19920601)69:11<2813::AID-CNCR2820691129>3.0.CO;2-W

M3 - Article

C2 - 1571913

AN - SCOPUS:0026596469

VL - 69

SP - 2813

EP - 2819

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 11

ER -